CURE - Oncology & Cancer News for Patients & Caregivers
Warmth, Friendship and Compassion in Cancer Care. December 31st 2024. Carla Chapman, a nurse at Dana-Farber Cancer Institute, is recognized for her unwavering support of patients, while Deb Christensen, an oncologist and patient advocate, dedicates her life to helping patients through volunteer work and education.
What Patients Should Know About Radiation Treatment for
Jul 25, 2024 · Radiopharmaceuticals, defined by the National Cancer Institute as drugs that contain radioactive substances, are at the forefront of treating patients with prostate cancer, as one radiation oncologist explained in an interview with CURE®.
20 Inspirational Quotes for Cancer Survivors, Fighters and
Aug 26, 2015 · Keeping a positive outlook is proven to help with stress management, but when someone says to "think positive" or "be optimistic" during a time such as cancer, it can be much easier said than done.
Pluvicto Improves Survival Without Progression in Certain
Oct 23, 2023 · Treatment with Pluvicto (177-Lu-PSMA-617) improved the duration of time when a patient’s disease did not progress with a favorable safety profile in patients with metastatic castration-resistant prostate cancer (mCRPC) who were taxane-naïve, according to recent results from a phase 3 trial.
What Patients with Prostate Cancer Need to Know About
Jul 16, 2024 · For patients with prostate cancer undergoing radiation, the side effect burden exists on a spectrum, as one nurse explained to CURE®. “Not one patient experiences everything to their full degree,” Jessica Fox, a radiation oncology nurse with Providence Cancer Institute in Portland, Oregon said during a conversation that was part of the “Speaking Out” video series.
PSMA-Targeted Radiation Drug for Prostate Cancer Subset Meets …
Nov 22, 2024 · Treatment with 177Lu-PSMA-I&T in patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (CRPC) demonstrated meaningful benefits in radiographic progression-free survival (PFS).
Transurethral Ultrasound Ablation a Promising Prostate Cancer …
Oct 14, 2024 · Patients with prostate cancer demonstrated reduced tumor volume and PSA levels, a key marker of prostate cancer progression, and experienced improved urinary function and maintained sexual function after undergoing Transurethral Ultrasound Ablation (TULSA), according to a study presented at the CURE® Educated Patient® Prostate Cancer Summit by Dr. Yair Lotan, a professor of urology at UT ...
Long-Term Follow-Up Shows Keytruda Continues to Improve
Feb 1, 2021 · Keytruda (pembrolizumab) continued to demonstrate a clinically meaningful improvement in overall and progression-free survival, compared with docetaxel, in patients with previously treated, PD-L1–positive advanced non-small cell lung cancer (NSCLC) after more than five years of follow-up, according to results from the phase 2/3 KEYNOTE-010 study presented at the 2020 World Conference on Lung ...
T-Cell Therapy With Lete-Cel Demonstrates Efficacy in Sarcoma …
Nov 23, 2024 · “Individuals with both synovial sarcoma and [myxoid/round cell liposarcoma] are commonly diagnosed under 40, facing a devastating disease with limited treatments in the prime of their lives,” Dr. Sandra D’Angelo, sarcoma medical oncologist and cell therapist at Memorial Sloan Kettering Cancer Center in New York, said in the release.
What Free Light Chains can tell us about Myeloma - Curetoday
Oct 10, 2016 · Okay, this is gonna sound complicated at first, but bear with me and let’s see if we can’t make it a bit easier… So, a diagnosis of multiple myeloma usually involves a blood test known as a “Serum Free Light Chain Assay”.